Scotia Capital Inc. Astrazeneca PLC Transaction History
Scotia Capital Inc.
- $17.9 Billion
- Q4 2024
A detailed history of Scotia Capital Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Scotia Capital Inc. holds 231,797 shares of AZN stock, worth $17.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
231,797
Previous 413,542
43.95%
Holding current value
$17.5 Million
Previous $32.2 Million
52.87%
% of portfolio
0.08%
Previous 0.18%
Shares
27 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...